Sur le marché américain des traitements contre l’obésité, les laboratoires Eli Lilly et Novo Nordisk se livrent une ...
Canada backs reimbursement for Kisunla; Lilly faces a 340B data lawsuit and Missouri order while guiding 2026 revenue to ...
Priced out of official prescriptions, Malaysians are buying unregulated slimming jabs online - with no guarantee of what's inside When her prescription for Mounjaro became too expensive, Bey* did what ...
SCHOTT Pharma's bull case relies on GLP-1 drug packaging demand, but recent competitor order cuts triggered market volatility ...
After a 57% run-up over the past 52 weeks, Eli Lilly (NYSE: LLY) shares are expensive. The stock is now trading at 47 times trailing earnings. That's more than double the price-to-earnings ratio of ...
Lillys Umsatz stieg im dritten Quartal um 39 Prozent; Klagen und behördliche Vorgaben könnten die Rabattpraxis beeinflussen.
Rick Orford - Trading Stocks and Options For All on MSN
How Eli Lilly could reach $1,500 a share
Rick Orford analyzes the revenue and profit milestones Eli Lilly would need to support a $1,500 share price. He reviews ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results